Home > Healthcare > Medical Devices > Therapeutic Devices > Patient-controlled Analgesic Pumps Market

Patient-controlled Analgesic Pumps Market Size

  • Report ID: GMI7971
  • Published Date: Jan 2024
  • Report Format: PDF

Patient-controlled Analgesic Pumps Market Size

Patient-Controlled Analgesic Pumps Market was valued at around USD 453.9 million in 2023 and is estimated to grow at 4.8% CAGR from 2024 to 2032. This robust market growth can be attributed to various factors, including the growing number of surgical procedures, an increase in the prevalence of chronic pain conditions, ongoing advancements in pain management technologies, and surging demand for non-invasive procedures, among other contributing factors.

 

Moreover, the ageing population is more prone to develop chronic health issues and require surgical treatments, causing a greater demand for effective pain management. Patient-controlled analgesia pumps are commonly used in elderly individuals to give personalized and regulated pain management. Therefore, increasing geriatric population is expected to considerably boost the market growth.

 

For instance, according to United Nations (UN) research report published in 2023, the number of people aged 65 and over globally is predicted to treble over the next three decades. The senior population is expected to reach 1.6 billion by 2050, accounting for more than 16% of the worldwide population. Furthermore, there is a growing focus on patient-centered care, where patients actively participate in decisions related to their treatment. Patient-controlled analgesic pumps align with this trend by allowing patients to have a degree of control over their pain management, enhancing their overall experience, thereby contributing to the market growth.

 

Patient-controlled analgesic (PCA) pumps are medical devices designed to administer pain medication to patients in a controlled and personalized manner. These pumps allow patients to self-administer doses of pain medication within preset limits, providing a level of autonomy in managing their pain. PCA pumps are commonly used in various healthcare settings, including hospitals, postoperative recovery units, and outpatient care settings.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Patient-controlled analgesic pumps industry reached USD 453.9 million in revenue in 2023 and is projected to be worth USD 697.4 million by 2032 driven by the increasing number of surgical procedures and the ongoing advancements in pain management technologies

The electronic and wireless segment generated USD 306.6 million in 2023 and is projected to gain significant traction through 2032 due to the strong need to enable remote monitoring and facilitate integration with telehealth platforms.

North America patient-controlled analgesic pumps industry size was USD 183.3 million in 2023 and is estimated to exhibit robust growth through 2032 driven by the growing prevalence of chronic pain problems and the presence of an advanced healthcare infrastructure in the region.

Some leading companies engaged in the market are B. Braun Medical Inc., Abbott Laboratories, Ace-medical, Becton, Dickinson and Company, Changzhou Medical Bioengineering Co., Ltd., Fresenius SE & Co. KGaA, Henan Tuoren Medical Device Co., Ltd., ICU Medical, Inc., Micrel Medical Devices SA, and SCW MEDICATH LTD.

Patient-controlled Analgesic Pumps Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 213
  • Countries covered: 22
  • Pages: 120
 Download Free Sample